BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen AW. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 2021. [PMID: 34184164 DOI: 10.1007/s10456-021-09805-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 24.5] [Reference Citation Analysis]
Number Citing Articles
1 Bhatt AS, Daniels LB, de Lemos J, Goodrich E, Bohula EA, Morrow DA; CCCTN Investigators. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Am Heart J 2023;258:149-56. [PMID: 36669711 DOI: 10.1016/j.ahj.2022.12.014] [Reference Citation Analysis]
2 Güven YZ, Kıratlı K, Kahraman HG, Akay F, Yurdakul ES. Evaluation of acute effects of pulmonary involvement and hypoxia on retina and choroid in coronavirus disease 2019: An optic coherence tomography study. Photodiagnosis Photodyn Ther 2022;41:103265. [PMID: 36592784 DOI: 10.1016/j.pdpdt.2022.103265] [Reference Citation Analysis]
3 Beauvais A, Gendron N, Philippe A, Vedie B, Loriot MA, Juvin P, Khider L, Sanchez O, Diehl JL, M Smadja D, Chocron R. Clinical usefulness of admission versus monitoring troponin in patients with coronavirus disease 2019. Arch Cardiovasc Dis 2023:S1875-2136(23)00012-8. [PMID: 36710144 DOI: 10.1016/j.acvd.2022.12.005] [Reference Citation Analysis]
4 Mezine F, Guerin CL, Philippe A, Gendron N, Soret L, Sanchez O, Mirault T, Diehl JL, Chocron R, Boulanger CM, Smadja DM. Increased Circulating CD62E(+) Endothelial Extracellular Vesicles Predict Severity and in- Hospital Mortality of COVID-19 Patients. Stem Cell Rev Rep 2023;19:114-9. [PMID: 35982357 DOI: 10.1007/s12015-022-10446-5] [Reference Citation Analysis]
5 Garmendia JV, García AH, De Sanctis CV, Hajdúch M, De Sanctis JB. Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19. Curr Issues Mol Biol 2022;45:33-50. [PMID: 36661489 DOI: 10.3390/cimb45010003] [Reference Citation Analysis]
6 Xu P, Wang LS, Zhou WH. [Clinical features of children with coronavirus disease 2019 complicated by acute encephalitis and related research advances]. Zhongguo Dang Dai Er Ke Za Zhi 2022;24:1301-6. [PMID: 36544407 DOI: 10.7499/j.issn.1008-8830.2208033] [Reference Citation Analysis]
7 Talotta R. Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects? Microorganisms 2022;10. [PMID: 36557705 DOI: 10.3390/microorganisms10122452] [Reference Citation Analysis]
8 Becker S, Jonigk D, Luft A, Dübbel L, Werlein C, Malik E, Schild-Suhren M. COVID-19 can lead to rapid progression of cervical intraepithelial neoplasia by dysregulating the immune system: A hypothesis. J Reprod Immunol 2022;154:103763. [PMID: 36399874 DOI: 10.1016/j.jri.2022.103763] [Reference Citation Analysis]
9 Abramov A, Su I, Agerstrand C, Flatley M, Dubois R, Feldhaus D, Stanifer BP, Sonett J, Brodie D, Lemaitre P. Extracorporeal Membrane Oxygenation Support in COVID-19 Patients: A Propensity Score Analysis. ASAIO J 2022;68:e224-9. [PMID: 36368023 DOI: 10.1097/MAT.0000000000001829] [Reference Citation Analysis]
10 Devaux CA, Camoin-jau L. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1042200] [Reference Citation Analysis]
11 Pons S, Uhel F, Frapy E, Sérémé Y, Zafrani L, Aschard H, Skurnik D. How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? Stem Cell Rev Rep 2022;:1-16. [PMID: 36422774 DOI: 10.1007/s12015-022-10477-y] [Reference Citation Analysis]
12 Pelisek J, Reutersberg B, Greber UF, Zimmermann A. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs. Clinical Science 2022;136:1571-1590. [DOI: 10.1042/cs20220235] [Reference Citation Analysis]
13 Peronino C, Guerin CL, Ivak P, Guyonnet L, Chocron R, Detriché G, Latremouille C, Gruest M, Philippe A, Capel A, Pya Y, Martin AC, Jansen P, Gendron N, Netuka I, Smadja DM. Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation. ASAIO J 2022;68:e173-8. [PMID: 36228635 DOI: 10.1097/MAT.0000000000001820] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Turner S, Naidoo CA, Usher TJ, Kruger A, Venter C, Laubscher GJ, Khan MA, Kell DB, Pretorius E. Increased levels of inflammatory molecules in blood of Long COVID patients point to thrombotic endotheliitis.. [DOI: 10.1101/2022.10.13.22281055] [Reference Citation Analysis]
15 Grobbelaar LM, Kruger A, Venter C, Burger EM, Laubscher GJ, Maponga TG, Kotze MJ, Kwaan HC, Miller JB, Fulkerson D, Huff W, Chang E, Wiarda G, Bunch CM, Walsh MM, Raza S, Zamlut M, Moore HB, Moore EE, Neal MD, Kell DB, Pretorius E. Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness. Semin Thromb Hemost 2022. [PMID: 36174604 DOI: 10.1055/s-0042-1756306] [Reference Citation Analysis]
16 Solimando AG, Marziliano D, Ribatti D. SARS-CoV-2 and Endothelial Cells: Vascular Changes, Intussusceptive Microvascular Growth and Novel Therapeutic Windows. Biomedicines 2022;10:2242. [DOI: 10.3390/biomedicines10092242] [Reference Citation Analysis]
17 Urueña C, Ballesteros-ramírez R, Gomez-cadena A, Barreto A, Prieto K, Quijano S, Aschner P, Martínez C, Zapata-cardona MI, El-ahanidi H, Jandus C, Florez-alvarez L, Rugeles MT, Zapata-builes W, Garcia AA, Fiorentino S. Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et). Front Med 2022;9. [DOI: 10.3389/fmed.2022.991873] [Reference Citation Analysis]
18 Smadja DM, Fellous BA, Bonnet G, Hauw-berlemont C, Sutter W, Beauvais A, Fauvel C, Philippe A, Weizman O, Mika D, Juvin P, Waldmann V, Diehl J, Cohen A, Chocron R. D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.935333] [Reference Citation Analysis]
19 Chien TJ, Liu CY, Chang YI, Fang CJ, Pai JH, Wu YX, Chen SW. Therapeutic effects of herbal-medicine combined therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 2022;13:950012. [PMID: 36120361 DOI: 10.3389/fphar.2022.950012] [Reference Citation Analysis]
20 Grobbelaar LM, Kruger A, Venter C, Burger EM, Laubscher GJ, Maponga TG, Kotze MJ, Kwaan HC, Miller JB, Fulkerson D, Huff W, Chang E, Wiarda G, Bunch CM, Walsh MM, Raza S, Zamlut M, Moore HB, Moore EE, Neal MD, Kell DB, Pretorius E. Relative hypercoagulopathy of the SARS-CoV-2 Beta and Delta variants when compared to the less severe Omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness.. [DOI: 10.21203/rs.3.rs-1970823/v1] [Reference Citation Analysis]
21 Osiaevi I, Schulze A, Evers G, Harmening K, Vink H, Kümpers P, Mohr M, Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis 2022. [PMID: 35951203 DOI: 10.1007/s10456-022-09850-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Griffioen AW, Nowak-Sliwinska P. Programmed cell death lives. Apoptosis 2022. [PMID: 35943678 DOI: 10.1007/s10495-022-01758-5] [Reference Citation Analysis]
23 Philippe A, Puel M, Narjoz C, Gendron N, Durey-Dragon MA, Vedie B, Balduyck M, Chocron R, Hauw-Berlemont C, Sanchez O, Mirault T, Diehl JL, Smadja DM, Loriot MA. Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19. Biochimie 2022:S0300-9084(22)00188-2. [PMID: 35952950 DOI: 10.1016/j.biochi.2022.07.012] [Reference Citation Analysis]
24 Falcinelli E, Petito E, Gresele P. The role of platelets, neutrophils and endothelium in COVID-19 infection. Expert Rev Hematol 2022. [PMID: 35930267 DOI: 10.1080/17474086.2022.2110061] [Reference Citation Analysis]
25 Romanov YA, Kosolapova YA, Zubkov VV, Degtyarev DN, Romanov AY, Dugina TN, Sukhikh GT. Mild or Moderate COVID-19 during Pregnancy Does Not Affect the Content of CD34+ Hematopoietic Stem Cells in Umbilical Cord Blood of Newborns. Bull Exp Biol Med 2022;173:523-528. [DOI: 10.1007/s10517-022-05575-3] [Reference Citation Analysis]
26 Griffioen AW, Dudley AC. The rising impact of angiogenesis research. Angiogenesis 2022. [PMID: 35881257 DOI: 10.1007/s10456-022-09849-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sarafidis M, Lambrou GI, Zoumpourlis V, Koutsouris D. An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer. Cancers (Basel) 2022;14:3358. [PMID: 35884419 DOI: 10.3390/cancers14143358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jiang Y, Yan Q, Liu C, Peng C, Zheng W, Zhuang H, Huang H, Liu Q, Liao H, Zhan S, Liu X, Huang X. Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid. Computers in Biology and Medicine 2022;146:105601. [DOI: 10.1016/j.compbiomed.2022.105601] [Reference Citation Analysis]
29 Drost CC, Rovas A, Osiaevi I, Rauen M, van der Vlag J, Buijsers B, Salmenov R, Lukasz A, Pavenstädt H, Linke WA, Kümpers P. Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept Study. Front Immunol 2022;13:916512. [PMID: 35757776 DOI: 10.3389/fimmu.2022.916512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Tricarico G, Travagli V. Approach to the management of COVID-19 patients: When home care can represent the best practice. Int J Risk Saf Med 2022. [PMID: 35786662 DOI: 10.3233/JRS-210064] [Reference Citation Analysis]
31 Rovas A, Buscher K, Osiaevi I, Drost CC, Sackarnd J, Tepasse PR, Fobker M, Kühn J, Braune S, Göbel U, Thölking G, Gröschel A, Rossaint J, Vink H, Lukasz A, Pavenstädt H, Kümpers P. Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study. Angiogenesis 2022. [PMID: 35723762 DOI: 10.1007/s10456-022-09843-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zha D, Fu M, Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells 2022;11:1972. [PMID: 35741101 DOI: 10.3390/cells11121972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Săbiescu DM, Kamal AM, Kamal CK, Alexandru DO, Mitruț P. Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver. J Med Life 2022;15:727-34. [PMID: 35928369 DOI: 10.25122/jml-2022-0177] [Reference Citation Analysis]
34 Jonigk D, Werlein C, Lee PD, Kauczor HU, Länger F, Ackermann M. Pulmonary and Systemic Pathology in COVID-19—Holistic Pathological Analyses. Dtsch Arztebl Int 2022;119:429-35. [PMID: 35698804 DOI: 10.3238/arztebl.m2022.0231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Gao L, Mathur V, Tam SKM, Zhou X, Cheung MF, Chan LY, Estrada-gutiérrez G, Leung BW, Moungmaithong S, Wang CC, Poon LC, Leung D. SARS-CoV-2 impacts the transcriptome and epigenome at the maternal-fetal interface in pregnancy.. [DOI: 10.1101/2022.05.31.494153] [Reference Citation Analysis]
36 Auditeau C, Khider L, Planquette B, Sanchez O, Smadja DM, Gendron N. D‐dimer testing in clinical practice in the era of COVID‐19. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12730] [Reference Citation Analysis]
37 Degen CV, Mikuteit M, Niewolik J, Schröder D, Vahldiek K, Mücke U, Heinemann S, Müller F, Behrens GMN, Klawonn F, Dopfer-Jablonka A, Steffens S. Self-reported Tinnitus and Vertigo or Dizziness in a Cohort of Adult Long COVID Patients. Front Neurol 2022;13:884002. [PMID: 35547372 DOI: 10.3389/fneur.2022.884002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Valderas C, Méndez G, Echeverría A, Suarez N, Julio K, Sandoval F. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner. World J Pediatr 2022. [PMID: 35476245 DOI: 10.1007/s12519-022-00550-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Franca CM, Mansoorifar A, Athirasala A, Subbiah R, Tahayeri A, Bertassoni L. Vascular inflammation exposes perivascular cells to SARS-CoV-2 infection.. [DOI: 10.1101/2022.04.05.487240] [Reference Citation Analysis]
40 Maldonado F, Morales D, Díaz-Papapietro C, Valdés C, Fernandez C, Valls N, Lazo M, Espinoza C, González R, Gutiérrez R, Jara Á, Romero C, Cerda O, Cáceres M. Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support. Front Med (Lausanne) 2022;9:826218. [PMID: 35372407 DOI: 10.3389/fmed.2022.826218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Skrzat-klapaczyńska A, Bieńkowski C, Kowalska J, Paciorek M, Puła J, Krogulec D, Stengiel J, Pawełczyk A, Perlejewski K, Osuch S, Radkowski M, Horban A. The Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center. Vaccines 2022;10:552. [DOI: 10.3390/vaccines10040552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Duijvelaar E, Schippers JR, Smeele PJ, de Raaf MA, Vanhove ALEM, Blok SG, Twisk JWR, Vonk Noordegraaf A, de Man FS, Bogaard HJ, Aman J; CounterCOVID Collaborative Group. Long-term clinical outcomes of COVID-19 patients treated with imatinib. Lancet Respir Med 2022;10:e34-5. [PMID: 35183270 DOI: 10.1016/S2213-2600(22)00052-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
44 Geronikolou SA, Takan I, Pavlopoulou A, Mantzourani M, Chrousos GP. Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia. Int J Mol Med 2022;49:35. [PMID: 35059730 DOI: 10.3892/ijmm.2022.5090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Liu C, Zhang Y, Niu L, Li J. High Level of the Fibrin Degradation Products at Admission Predicts Parenchymal Hematoma and Unfavorable Outcome of Ischemic Stroke After Intravenous Thrombolysis. Front Neurol 2022;12:797394. [DOI: 10.3389/fneur.2021.797394] [Reference Citation Analysis]
46 Romanov Y. SARS-CoV-2, COVID-19 and cardiovascular complications from the position of vascular endothelium. Kardio vestn 2022;17:21. [DOI: 10.17116/cardiobulletin20221701121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zhang Y, Wang H, Oliveira RHM, Zhao C, Popel AS. Systems biology of angiogenesis signaling: Computational models and omics. WIREs Mech Dis 2021;:e1550. [PMID: 34970866 DOI: 10.1002/wsbm.1550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Pape T, Hunkemöller AM, Kümpers P, Haller H, David S, Stahl K. Targeting the "sweet spot" in septic shock - A perspective on the endothelial glycocalyx regulating proteins Heparanase-1 and -2. Matrix Biol Plus 2021;12:100095. [PMID: 34917926 DOI: 10.1016/j.mbplus.2021.100095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, Bulla R. COVID-19, Pre-Eclampsia, and Complement System. Front Immunol 2021;12:775168. [PMID: 34868042 DOI: 10.3389/fimmu.2021.775168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
50 Smadja DM, Bory OM, Diehl J, Mareau A, Gendron N, Jannot A, Chocron R. Daily Monitoring of D-Dimer Allows Outcomes Prediction in COVID-19. TH Open 2022;06:e21-5. [DOI: 10.1055/a-1709-5441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Boaz M, Navarro DA, Raz O, Kaufman-Shriqui V. Dietary Changes and Anxiety during the Coronavirus Pandemic: Differences between the Sexes. Nutrients 2021;13:4193. [PMID: 34959744 DOI: 10.3390/nu13124193] [Reference Citation Analysis]
52 Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. J Clin Med 2021;10:5381. [PMID: 34830660 DOI: 10.3390/jcm10225381] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
53 Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, Frémeaux-Bacchi V, Terrier B. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. J Allergy Clin Immunol 2021:S0091-6749(21)01761-9. [PMID: 34800432 DOI: 10.1016/j.jaci.2021.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
54 Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, Monkman J, Dos Santos Miggiolaro AFR, Cooper C, de Noronha L, Schroder K, Lagendijk AK, Labzin LI, Short KR, Gordon EJ. Endothelial cells are not productively infected by SARS-CoV-2. Clin Transl Immunology 2021;10:e1350. [PMID: 34721846 DOI: 10.1002/cti2.1350] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
55 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
56 Bojkova D, Costa R, Reus P, Bechtel M, Jaboreck MC, Olmer R, Martin U, Ciesek S, Michaelis M, Cinatl J Jr. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy. Metabolites 2021;11:699. [PMID: 34677415 DOI: 10.3390/metabo11100699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
57 Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care 2021;11:113. [PMID: 34273008 DOI: 10.1186/s13613-021-00899-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
58 Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. Early management of severe COVID-19 coagulopathy should be guided by TEG®, microclot and platelet mapping.. [DOI: 10.1101/2021.07.05.21260012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Philippe A, Gendron N, Bory O, Beauvais A, Mirault T, Planquette B, Sanchez O, Diehl JL, Chocron R, Smadja DM. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis 2021;24:407-11. [PMID: 33974165 DOI: 10.1007/s10456-021-09789-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
60 Henry BM, de Oliveira MHS, Cheruiyot I, Benoit JL, Cooper DS, Lippi G, Le Cras TD, Benoit SW. Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis 2021;24:403-6. [PMID: 33755876 DOI: 10.1007/s10456-021-09782-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]